One study suggests that SGLT2 inhibitors may exert cardioprotective effects by inhibiting autophagy in cardiomyocytes, thereby improving survival rates in mice with MI accompanied by acute hyperglycemia [39]. Here, SLC5A2 is linked to myocardial infarction.